# Bank of the James Financial Group Inc: financial statements, quarterly

BOTJ · Nasdaq · CIK 1275101 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/botj.md) · [Financials](/companies/botj/financials.md) · [Filings](/companies/botj/filings.md) · [Insiders](/companies/botj/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/botj/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,004](/filings/0001562762-24-000273.md) | [959 d](/filings/0001562762-25-000054.md) | [953](/filings/0001562762-25-000129.md) | [986](/filings/0001562762-25-000212.md) | [991](/filings/0001275101-25-000007.md) | [1,073 d](/filings/0001275101-26-000010.md) | [981](/filings/0001275101-26-000019.md) | [975](/filings/0001275101-26-000025.md) | [1,046](/filings/0001275101-25-000007.md) | [1,271 d](/filings/0001275101-26-000010.md) | [994](/filings/0001275101-26-000019.md) | [1,149](/filings/0001275101-26-000025.md) |
| Interest expense | $k | [2,779](/filings/0001562762-23-000418.md) | [3,149 d](/filings/0001562762-24-000069.md) | [3,559](/filings/0001562762-24-000144.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [511](/filings/0001562762-24-000273.md) | [(56.0) d](/filings/0001562762-25-000054.md) | [535](/filings/0001562762-25-000129.md) | [518](/filings/0001562762-25-000212.md) | [474](/filings/0001275101-25-000007.md) | [452 d](/filings/0001275101-26-000010.md) | [197](/filings/0001275101-26-000019.md) | [694](/filings/0001275101-26-000025.md) | [466](/filings/0001275101-25-000007.md) | [766 d](/filings/0001275101-26-000010.md) | [705](/filings/0001275101-26-000019.md) | [829](/filings/0001275101-26-000025.md) |
| Net income | $k | [2,078](/filings/0001562762-24-000273.md) | [2,108 d](/filings/0001562762-25-000054.md) | [2,188](/filings/0001275101-25-000007.md) | [2,148](/filings/0001275101-25-000007.md) | [1,990](/filings/0001275101-25-000007.md) | [1,618 d](/filings/0001275101-26-000010.md) | [842](/filings/0001275101-26-000025.md) | [2,704](/filings/0001275101-26-000025.md) | [2,752](/filings/0001275101-25-000007.md) | [2,723 d](/filings/0001275101-26-000010.md) | [2,774](/filings/0001275101-26-000025.md) | [3,240](/filings/0001275101-26-000025.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001562762-24-000273.md) | not reported | [0.48](/filings/0001562762-25-000129.md) | [0.47](/filings/0001562762-25-000212.md) | [0.44](/filings/0001275101-25-000007.md) | not reported | [0.19](/filings/0001275101-26-000019.md) | [0.60](/filings/0001275101-26-000025.md) | [0.61](/filings/0001275101-25-000007.md) | not reported | [0.61](/filings/0001275101-26-000019.md) | [0.71](/filings/0001275101-26-000025.md) |
| Basic EPS | $ per share | [0.46](/filings/0001562762-24-000273.md) | not reported | [0.48](/filings/0001562762-25-000129.md) | [0.47](/filings/0001562762-25-000212.md) | [0.44](/filings/0001275101-25-000007.md) | not reported | [0.19](/filings/0001275101-26-000019.md) | [0.60](/filings/0001275101-26-000025.md) | [0.61](/filings/0001275101-25-000007.md) | not reported | [0.61](/filings/0001275101-26-000019.md) | [0.71](/filings/0001275101-26-000025.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [961](/filings/0001562762-24-000273.md) | [969](/filings/0001562762-25-000054.md) | [985](/filings/0001562762-25-000129.md) | [978](/filings/0001562762-25-000212.md) | [1,008](/filings/0001275101-25-000007.md) | [979](/filings/0001275101-26-000010.md) | [1,012](/filings/0001275101-26-000019.md) | [1,004](/filings/0001275101-26-000025.md) | [1,020](/filings/0001275101-25-000007.md) | [1,039](/filings/0001275101-26-000025.md) | [1,061](/filings/0001275101-26-000019.md) | [1,041](/filings/0001275101-26-000025.md) |
| Total liabilities | $m | [911](/filings/0001562762-23-000418.md) | [909](/filings/0001562762-25-000054.md) | [924](/filings/0001562762-24-000144.md) | [916](/filings/0001562762-24-000205.md) | [939](/filings/0001562762-24-000273.md) | [914](/filings/0001275101-26-000010.md) | [943](/filings/0001562762-25-000129.md) | [933](/filings/0001562762-25-000212.md) | [943](/filings/0001275101-25-000007.md) | [959](/filings/0001275101-26-000025.md) | [980](/filings/0001275101-26-000019.md) | [958](/filings/0001275101-26-000025.md) |
| Shareholders' equity | $m | [50.1](/filings/0001562762-24-000273.md) | [60.0](/filings/0001275101-26-000010.md) | [60.4](/filings/0001275101-25-000007.md) | [61.7](/filings/0001275101-25-000007.md) | [68.8](/filings/0001275101-25-000007.md) | [64.9](/filings/0001275101-26-000025.md) | [68.3](/filings/0001275101-26-000025.md) | [71.7](/filings/0001275101-26-000025.md) | [77.0](/filings/0001275101-25-000007.md) | [80.0](/filings/0001275101-26-000025.md) | [81.3](/filings/0001275101-26-000025.md) | [83.2](/filings/0001275101-26-000025.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,373 d](/filings/0001562762-24-000273.md) | [3,523 d](/filings/0001562762-25-000054.md) | [(1,230)](/filings/0001562762-25-000129.md) | [2,883 d](/filings/0001562762-25-000212.md) | [4,970 d](/filings/0001275101-25-000007.md) | [1,886 d](/filings/0001275101-26-000010.md) | [763](/filings/0001275101-26-000019.md) | [3,653 d](/filings/0001275101-26-000025.md) | [5,270 d](/filings/0001275101-25-000007.md) | [1,974 d](/filings/0001275101-26-000010.md) | [4,739](/filings/0001275101-26-000019.md) | [632 d](/filings/0001275101-26-000025.md) |
| Capital expenditure | $k | [1,168 d](/filings/0001562762-24-000273.md) | [96.0 d](/filings/0001562762-25-000054.md) | [479](/filings/0001562762-25-000129.md) | [113 d](/filings/0001562762-25-000212.md) | [1,617 d](/filings/0001275101-25-000007.md) | [341 d](/filings/0001275101-26-000010.md) | [622](/filings/0001275101-26-000019.md) | [125 d](/filings/0001275101-26-000025.md) | [(215) d](/filings/0001275101-25-000007.md) | [633 d](/filings/0001275101-26-000010.md) | [382](/filings/0001275101-26-000019.md) | [300 d](/filings/0001275101-26-000025.md) |
| Dividends paid | $k | [366 d](/filings/0001562762-24-000273.md) | [361 d](/filings/0001562762-25-000054.md) | [453](/filings/0001562762-25-000129.md) | [457 d](/filings/0001562762-25-000212.md) | [454 d](/filings/0001275101-25-000007.md) | [454 d](/filings/0001275101-26-000010.md) | [455](/filings/0001275101-26-000019.md) | [455 d](/filings/0001275101-26-000025.md) | [454 d](/filings/0001275101-25-000007.md) | [453 d](/filings/0001275101-26-000010.md) | [455](/filings/0001275101-26-000019.md) | [454 d](/filings/0001275101-26-000025.md) |
| Share repurchases | $k | [0.0 d](/filings/0001562762-24-000273.md) | [0.0 d](/filings/0001562762-25-000054.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,684](/filings/0001562762-23-000418.md) | [4,619](/filings/0001562762-24-000144.md) | [4,545](/filings/0001562762-24-000205.md) | [4,543](/filings/0001562762-24-000273.md) | [4,543](/filings/0001562762-25-000129.md) | [4,543](/filings/0001562762-25-000212.md) | [4,543](/filings/0001275101-25-000007.md) | [4,543](/filings/0001275101-26-000019.md) | [4,543](/filings/0001275101-26-000025.md) | [4,543](/filings/0001275101-25-000007.md) | [4,543](/filings/0001275101-26-000019.md) | [4,543](/filings/0001275101-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,543,338 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001275101-26-000025.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.